{"gene":"LAS1L","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":2010,"finding":"LAS1L is a nucleolar protein required for cell proliferation and ribosome biogenesis; depletion of LAS1L inhibits rRNA processing, blocks synthesis of mature 28S rRNA, and causes p53-dependent G1 arrest.","method":"siRNA knockdown in human cells, rRNA processing analysis (Northern blot), cell cycle analysis by flow cytometry","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — clean KD with defined cellular and molecular phenotypes, multiple orthogonal readouts","pmids":["20647540"],"is_preprint":false},{"year":2011,"finding":"LAS1L forms a novel nucleolar complex with PELP1, TEX10, WDR18 (mammalian Rix1 complex homologues), NOL9, and SENP3 that co-fractionates with the 60S preribosomal subunit; depletion of complex members causes p53-dependent G1 arrest and defects in ITS2 pre-rRNA processing; nucleolar localization of this complex requires active RNA Pol I transcription and the SUMO protease SENP3.","method":"Co-immunoprecipitation, sucrose gradient fractionation, siRNA knockdown, rRNA processing analysis, RNA Pol I inhibition, SENP3 depletion","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IPs, co-fractionation, multiple knockdowns with defined molecular phenotypes","pmids":["22190735"],"is_preprint":false},{"year":2011,"finding":"In both budding yeast and human cells, Las1/LAS1L is required for ITS2 processing: in yeast it is needed for Rrp6-dependent formation of the 5.8S rRNA 3' end and for Rat1-dependent formation of the 25S rRNA 5' end, indicating coordinated pre-rRNA processing at both ends of ITS2.","method":"Genetic depletion/mutant analysis in S. cerevisiae and human cells, Northern blot rRNA processing analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — cross-species genetic analysis with defined molecular phenotypes replicated in two organisms","pmids":["22083961"],"is_preprint":false},{"year":2012,"finding":"Yeast Las1 functions in ribosome biogenesis by associating with 27S rRNA and the Nsa1/Rix1-containing pre-60S particle; Grc3 is a major Las1-interacting protein, and the kinase activity of Grc3 is required for efficient pre-rRNA processing — depletion of either Las1 or Grc3 causes accumulation of 27S and 7S rRNA intermediates and impairs 60S subunit synthesis.","method":"Co-immunoprecipitation, sucrose gradient fractionation, yeast genetic depletion, in vivo kinase assay, Northern blot","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods, functional kinase requirement established by mutagenesis","pmids":["23175604"],"is_preprint":false},{"year":2015,"finding":"Las1 is the long-sought endonuclease that cleaves 27SB pre-rRNA at site C2, generating a 5'-OH end at 26S pre-rRNA and a 2',3'-cyclic phosphate at the 3' end of 7S pre-rRNA; it assembles with Grc3, Rat1, and Rai1 into a four-subunit RNA processome (Las1 complex) where Grc3 subsequently phosphorylates the 5'-OH of 26S pre-rRNA enabling Rat1-Rai1 exonuclease to generate 25S' pre-rRNA, thus coordinately removing ITS2.","method":"In vitro reconstitution of endonuclease activity, biochemical fractionation, mutational analysis, RNA substrate assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution of enzymatic activities with mutational validation, multiple orthogonal assays","pmids":["26638174"],"is_preprint":false},{"year":2017,"finding":"The Grc3 polynucleotide kinase programs Las1 endoribonuclease for specific C2 cleavage: Grc3 drives Las1 nuclease activity to the targeted C2 site both in vitro and in vivo; Las1 reciprocally activates Grc3 kinase activity exclusively toward single-stranded RNA; together they form a tetrameric complex required for competent rRNA processing, with parallels to the RNaseL/Ire1 RNA splicing family.","method":"In vitro endonuclease and kinase assays, yeast genetics, co-immunoprecipitation, biochemical reconstitution of tetrameric complex","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mutagenesis confirmed in vivo, bidirectional activation demonstrated","pmids":["28652339"],"is_preprint":false},{"year":2018,"finding":"Grc3 has distinct substrate preference for RNA (over DNA) as a polynucleotide kinase; specific conserved residues at the Grc3 kinase active site are required for Grc3-directed Las1-mediated pre-rRNA cleavage both in vitro and in vivo; the Grc3–Las1 crosstalk directly couples cleavage and phosphorylation during pre-rRNA processing.","method":"In vitro kinase assays with RNA/DNA substrates, site-directed mutagenesis of kinase active site, in vivo yeast complementation assays","journal":"RNA (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic assays with mutagenesis validated in vivo","pmids":["29440475"],"is_preprint":false},{"year":2020,"finding":"Las1 is a HEPN domain-containing endoribonuclease; both HEPN nuclease motifs (forming a composite active site) are required for Las1 nuclease activity and fidelity; conformational flexibility of the two HEPN domains is important for proper RNA cleavage; systematic mutagenesis defined the consensus Las1 HEPN motif with canonical and specialized elements.","method":"In vitro nuclease assays, in vivo S. cerevisiae complementation, systematic site-directed mutagenesis, Las1 HEPN-HEPN' chimera reconstitution, sequence analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with extensive mutagenesis, validated in vivo","pmids":["32220933"],"is_preprint":false},{"year":2023,"finding":"Covalent binding of the compound HEN-463 to C264 of LAS1 disrupts the LAS1–NOL9 interaction, causing LAS1 translocation to the cytoplasm and inhibiting 28S rRNA maturation; this activates the NPM1-MDM2-p53 pathway leading to p53 stabilization in NPM1-mutant AML cells.","method":"Chemical biology (covalent inhibitor), co-immunoprecipitation, subcellular fractionation, rRNA processing analysis, cell viability and apoptosis assays","journal":"Pharmacological research","confidence":"Medium","confidence_rationale":"Tier 2 — direct covalent targeting with defined molecular consequences, but single-lab study","pmids":["36796466"],"is_preprint":false},{"year":2024,"finding":"USP36 interacts with both LAS1L and NOL9, stabilizes them via deubiquitination, and mediates SUMOylation of LAS1L predominantly at lysine K565; the K565R SUMOylation-deficient mutant cannot rescue ITS2 processing defects caused by endogenous LAS1L knockdown, demonstrating that USP36-mediated LAS1L SUMOylation is required for ITS2 pre-rRNA processing.","method":"Co-immunoprecipitation, deubiquitination assays, SUMOylation assays, site-directed mutagenesis (K565R), siRNA rescue experiments, Northern blot rRNA processing analysis","journal":"Cancer research communications","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IPs, enzymatic assays, mutagenesis rescue experiment with defined molecular phenotype","pmids":["39356143"],"is_preprint":false},{"year":2022,"finding":"hnRNPA1 directly binds to LAS1L pre-mRNA at two intronic sites (UAGGGU and UGGGGU in intron 9) to inhibit splicing of LAS1L exon 9; the ratio of long (LAS1L-L) to short (LAS1L-S) isoforms regulated by hnRNPA1 promotes migration, invasion, and EMT in lung cancer cells.","method":"RIP assay, RNA pull-down assay, AGE splicing assay, Transwell migration/invasion assays, siRNA knockdown","journal":"Frontiers in oncology","confidence":"Medium","confidence_rationale":"Tier 2–3 — direct RNA binding demonstrated by RIP and pull-down, functional consequence of isoform ratio established, single lab","pmids":["35814393"],"is_preprint":false}],"current_model":"LAS1L is a nucleolar HEPN-domain endoribonuclease that, together with the polynucleotide kinase NOL9/Grc3 (and the Rat1-Rai1 exonuclease), forms the Las1 complex required for coordinated cleavage of 27SB pre-rRNA at site C2 and subsequent phosphorylation and exonucleolytic trimming to remove ITS2, thereby driving 60S ribosomal subunit maturation; in mammalian cells it additionally assembles with the Rix1-like complex (PELP1, TEX10, WDR18) and SENP3 in a nucleolar complex whose localization depends on active RNA Pol I transcription, and its activity is post-translationally regulated by USP36-mediated deubiquitination and SUMOylation at K565."},"narrative":{"teleology":[{"year":2010,"claim":"Establishing that LAS1L is required for ribosome biogenesis resolved the cellular role of this uncharacterized nucleolar protein, showing that its depletion blocks 28S rRNA maturation and triggers p53-dependent growth arrest.","evidence":"siRNA knockdown in human cells with Northern blot rRNA processing analysis and flow cytometry","pmids":["20647540"],"confidence":"High","gaps":["Enzymatic activity unknown","Direct rRNA substrate not identified","Mechanism of rRNA processing block undefined"]},{"year":2011,"claim":"Identification of the LAS1L-PELP1-TEX10-WDR18-NOL9-SENP3 nucleolar complex and its co-fractionation with pre-60S subunits established the multiprotein context in which LAS1L functions and linked its localization to active RNA Pol I transcription and SENP3-dependent SUMOylation.","evidence":"Reciprocal co-immunoprecipitation, sucrose gradient fractionation, siRNA knockdown, and RNA Pol I inhibition in human cells; cross-species genetic analysis in yeast and human cells","pmids":["22190735","22083961"],"confidence":"High","gaps":["Whether LAS1L is the direct endonuclease or an accessory factor was unknown","Stoichiometry of the complex undefined","Role of individual subunits in catalysis unresolved"]},{"year":2012,"claim":"Demonstration that Grc3/NOL9 is the principal Las1-interacting partner and that its kinase activity is required for pre-rRNA processing established the functional coupling between Las1 and Grc3 within the pre-60S particle.","evidence":"Co-immunoprecipitation, yeast genetic depletion, in vivo kinase assays, Northern blot","pmids":["23175604"],"confidence":"High","gaps":["Las1 catalytic activity not yet demonstrated biochemically","Nature of the Las1-Grc3 crosstalk unresolved"]},{"year":2015,"claim":"In vitro reconstitution proved Las1 is the long-sought C2 endonuclease, generating a 2',3'-cyclic phosphate and a 5'-OH that Grc3 phosphorylates to enable Rat1-Rai1 exonuclease activity — resolving how ITS2 removal is coordinately executed by a four-subunit Las1 complex.","evidence":"In vitro endonuclease reconstitution with purified components, mutational analysis, RNA substrate assays","pmids":["26638174"],"confidence":"High","gaps":["Structural basis of C2 site specificity unknown","How Grc3 directs Las1 to C2 unresolved","HEPN domain contribution not yet dissected"]},{"year":2017,"claim":"Reciprocal activation between Las1 and Grc3 was demonstrated — Grc3 programs Las1 for site-specific C2 cleavage while Las1 activates Grc3 kinase toward RNA — revealing the bidirectional allosteric mechanism governing coordinated ITS2 processing.","evidence":"In vitro endonuclease/kinase assays, yeast genetics, biochemical reconstitution of tetrameric complex","pmids":["28652339"],"confidence":"High","gaps":["Structural basis of allosteric communication unknown","Whether conformational states regulate activity in vivo untested"]},{"year":2018,"claim":"Characterization of Grc3 substrate specificity (RNA over DNA) and identification of active-site residues required for Las1-coupled cleavage refined the kinase mechanism and confirmed that cleavage–phosphorylation coupling is direct.","evidence":"In vitro kinase assays with RNA/DNA substrates, site-directed mutagenesis, yeast complementation","pmids":["29440475"],"confidence":"High","gaps":["Kinetic parameters of coupled reaction not determined","Whether additional cofactors modulate kinase selectivity unknown"]},{"year":2020,"claim":"Systematic mutagenesis of the Las1 HEPN domain defined the composite active site formed by two HEPN motifs, established that conformational flexibility between HEPN domains is required for cleavage fidelity, and confirmed Las1 as a bona fide HEPN endoribonuclease.","evidence":"In vitro nuclease assays, HEPN-HEPN' chimera reconstitution, extensive site-directed mutagenesis, yeast complementation","pmids":["32220933"],"confidence":"High","gaps":["No high-resolution structure of Las1 HEPN domain available","Mechanism of cleavage site selection at nucleotide resolution unresolved"]},{"year":2022,"claim":"Discovery that hnRNPA1 regulates LAS1L alternative splicing by binding intronic sequences to modulate the ratio of long and short isoforms revealed a layer of pre-mRNA-level regulation with phenotypic consequences for cell migration.","evidence":"RIP assay, RNA pull-down, splicing assays, Transwell migration/invasion in lung cancer cells","pmids":["35814393"],"confidence":"Medium","gaps":["Functional difference between LAS1L-L and LAS1L-S isoforms in ribosome biogenesis not defined","Relevance beyond lung cancer cells untested","Single-lab finding"]},{"year":2023,"claim":"Covalent targeting of LAS1L at C264 by HEN-463 disrupted the LAS1L–NOL9 interaction, caused cytoplasmic translocation, and blocked 28S rRNA maturation, activating the NPM1-MDM2-p53 axis — demonstrating LAS1L druggability and linking ribosome biogenesis disruption to p53 activation in AML cells.","evidence":"Chemical biology (covalent inhibitor), co-immunoprecipitation, subcellular fractionation, rRNA processing analysis in NPM1-mutant AML cells","pmids":["36796466"],"confidence":"Medium","gaps":["Selectivity of HEN-463 across the proteome not fully profiled","In vivo efficacy untested","Single-lab study"]},{"year":2024,"claim":"USP36 was shown to deubiquitinate and stabilize LAS1L and NOL9, and to mediate SUMOylation of LAS1L at K565; the K565R mutation failed to rescue ITS2 processing, establishing that SUMOylation is functionally required for LAS1L endonuclease activity in cells.","evidence":"Co-immunoprecipitation, deubiquitination/SUMOylation assays, K565R mutagenesis rescue, Northern blot rRNA processing","pmids":["39356143"],"confidence":"High","gaps":["How SUMOylation at K565 modulates LAS1L activity mechanistically is unknown","Whether additional SUMOylation sites contribute is untested","Structural impact of SUMO conjugation unresolved"]},{"year":null,"claim":"No high-resolution structure of the human LAS1L–NOL9 complex exists, the mechanism by which HEPN domain conformational dynamics achieve C2 site selectivity is unresolved, and the functional distinction between LAS1L splice isoforms in ribosome biogenesis remains undefined.","evidence":"","pmids":[],"confidence":"High","gaps":["No cryo-EM or crystal structure of human Las1 complex","Nucleotide-level basis of C2 recognition unknown","In vivo roles of LAS1L-L versus LAS1L-S isoforms undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[4,5,7]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[4,5,7]}],"localization":[{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[0,1]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,1]}],"pathway":[{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[4,5,7]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[0,2,4,5,7,9]}],"complexes":["Las1 complex (Las1-Grc3-Rat1-Rai1)","Rix1-like complex (PELP1-TEX10-WDR18-LAS1L-NOL9-SENP3)"],"partners":["NOL9","PELP1","TEX10","WDR18","SENP3","USP36","HNRNPA1"],"other_free_text":[]},"mechanistic_narrative":"LAS1L is a nucleolar HEPN-domain endoribonuclease essential for 60S ribosomal subunit maturation, functioning as the endonuclease that cleaves 27SB pre-rRNA at site C2 within ITS2 [PMID:26638174]. It assembles with the polynucleotide kinase NOL9/Grc3 into a tetrameric complex in which the two enzymes reciprocally activate each other: LAS1L cleavage generates a 5'-OH substrate that NOL9/Grc3 phosphorylates to enable Rat1-Rai1 exonucleolytic trimming, thereby coordinately removing ITS2 [PMID:26638174, PMID:28652339]. In mammalian cells, LAS1L further associates with the Rix1-like complex (PELP1, TEX10, WDR18) and the SUMO protease SENP3, whose nucleolar localization depends on active RNA Pol I transcription, and its activity is post-translationally regulated by USP36-mediated deubiquitination and SUMOylation at K565, both required for ITS2 processing [PMID:22190735, PMID:39356143]. Loss of LAS1L blocks 28S rRNA synthesis, triggers nucleolar stress, and activates p53-dependent G1 arrest [PMID:20647540]."},"prefetch_data":{"uniprot":{"accession":"Q9Y4W2","full_name":"Ribosomal biogenesis protein LAS1L","aliases":["Endoribonuclease LAS1L","Protein LAS1 homolog"],"length_aa":734,"mass_kda":83.1,"function":"Required for the synthesis of the 60S ribosomal subunit and maturation of the 28S rRNA (PubMed:20647540). Functions as a component of the Five Friends of Methylated CHTOP (5FMC) complex; the 5FMC complex is recruited to ZNF148 by methylated CHTOP, leading to desumoylation of ZNF148 and subsequent transactivation of ZNF148 target genes (PubMed:22872859). Required for the efficient pre-rRNA processing at both ends of internal transcribed spacer 2 (ITS2) (PubMed:22083961)","subcellular_location":"Nucleus, nucleolus; Nucleus, nucleoplasm; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q9Y4W2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/LAS1L","classification":"Common Essential","n_dependent_lines":1123,"n_total_lines":1208,"dependency_fraction":0.929635761589404},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"SLC16A10","stoichiometry":10.0},{"gene":"CAPRIN1","stoichiometry":0.2},{"gene":"CTCF","stoichiometry":0.2},{"gene":"DDOST","stoichiometry":0.2},{"gene":"DNTTIP1","stoichiometry":0.2},{"gene":"DRG1","stoichiometry":0.2},{"gene":"IPO5","stoichiometry":0.2},{"gene":"NPM1","stoichiometry":0.2},{"gene":"NPM3","stoichiometry":0.2},{"gene":"OST4","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/LAS1L","total_profiled":1310},"omim":[{"mim_id":"620304","title":"NUCLEOLAR PROTEIN 9; NOL9","url":"https://www.omim.org/entry/620304"},{"mim_id":"620291","title":"WD REPEAT-CONTAINING PROTEIN 18; WDR18","url":"https://www.omim.org/entry/620291"},{"mim_id":"618738","title":"TUBULIN TYROSINE LIGASE-LIKE 4; TTLL4","url":"https://www.omim.org/entry/618738"},{"mim_id":"609455","title":"PROLINE-, GLUTAMIC ACID-, AND LEUCINE-RICH PROTEIN 1; PELP1","url":"https://www.omim.org/entry/609455"},{"mim_id":"309585","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WILSON-TURNER TYPE; WTS","url":"https://www.omim.org/entry/309585"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Primary cilium transition zone","reliability":"Additional"},{"location":"Centriolar satellite","reliability":"Additional"},{"location":"Centrosome","reliability":"Additional"},{"location":"Basal body","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/LAS1L"},"hgnc":{"alias_symbol":["FLJ12525","Las1"],"prev_symbol":[]},"alphafold":{"accession":"Q9Y4W2","domains":[{"cath_id":"-","chopping":"49-199","consensus_level":"high","plddt":81.3583,"start":49,"end":199}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y4W2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y4W2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y4W2-F1-predicted_aligned_error_v6.png","plddt_mean":62.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=LAS1L","jax_strain_url":"https://www.jax.org/strain/search?query=LAS1L"},"sequence":{"accession":"Q9Y4W2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y4W2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y4W2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y4W2"}},"corpus_meta":[{"pmid":"22190735","id":"PMC_22190735","title":"LAS1L interacts with the mammalian Rix1 complex to regulate ribosome biogenesis.","date":"2011","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/22190735","citation_count":89,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26638174","id":"PMC_26638174","title":"Coordinated Ribosomal ITS2 RNA Processing by the Las1 Complex Integrating Endonuclease, Polynucleotide Kinase, and Exonuclease Activities.","date":"2015","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/26638174","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22083961","id":"PMC_22083961","title":"The evolutionarily conserved protein Las1 is required for pre-rRNA processing at both ends of ITS2.","date":"2011","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22083961","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20647540","id":"PMC_20647540","title":"Las1L is a nucleolar protein required for cell proliferation and ribosome biogenesis.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20647540","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31950540","id":"PMC_31950540","title":"Circ_LAS1L regulates cardiac fibroblast activation, growth, and migration through miR-125b/SFRP5 pathway.","date":"2020","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/31950540","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23175604","id":"PMC_23175604","title":"Las1 interacts with Grc3 polynucleotide kinase and is required for ribosome synthesis in Saccharomyces cerevisiae.","date":"2012","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/23175604","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8582632","id":"PMC_8582632","title":"LAS1 is an essential nuclear protein involved in cell morphogenesis and cell surface growth.","date":"1995","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8582632","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28652339","id":"PMC_28652339","title":"Grc3 programs the essential endoribonuclease Las1 for specific RNA cleavage.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28652339","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30556886","id":"PMC_30556886","title":"GAS5 promotes myocardial apoptosis in myocardial ischemia-reperfusion injury via upregulating LAS1 expression.","date":"2018","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30556886","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32220933","id":"PMC_32220933","title":"It takes two (Las1 HEPN endoribonuclease domains) to cut RNA correctly.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32220933","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29440475","id":"PMC_29440475","title":"Characterization of the molecular crosstalk within the essential Grc3/Las1 pre-rRNA processing complex.","date":"2018","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/29440475","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35814393","id":"PMC_35814393","title":"Knockdown of hnRNPA1 Promotes NSCLC Metastasis and EMT by Regulating Alternative Splicing of LAS1L exon 9.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35814393","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36796466","id":"PMC_36796466","title":"Covalent targeting the LAS1-NOL9 axis for selective treatment in NPM1 mutant acute myeloid leukemia.","date":"2023","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/36796466","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39356143","id":"PMC_39356143","title":"USP36 SUMOylates Las1L and Promotes Its Function in Pre-Ribosomal RNA ITS2 Processing.","date":"2024","source":"Cancer research communications","url":"https://pubmed.ncbi.nlm.nih.gov/39356143","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35627110","id":"PMC_35627110","title":"Severe Infantile Axonal Neuropathy with Respiratory Failure Caused by Novel Mutation in X-Linked LAS1L Gene.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/35627110","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22658674","id":"PMC_22658674","title":"Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22658674","citation_count":1718,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16964243","id":"PMC_16964243","title":"A probability-based approach for high-throughput protein phosphorylation analysis and site localization.","date":"2006","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/16964243","citation_count":1336,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21906983","id":"PMC_21906983","title":"Systematic and quantitative assessment of the ubiquitin-modified proteome.","date":"2011","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/21906983","citation_count":1334,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22681889","id":"PMC_22681889","title":"The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22681889","citation_count":973,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15635413","id":"PMC_15635413","title":"Nucleolar proteome dynamics.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15635413","citation_count":934,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15772651","id":"PMC_15772651","title":"The DNA sequence of the human X chromosome.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15772651","citation_count":816,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21890473","id":"PMC_21890473","title":"A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles.","date":"2011","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/21890473","citation_count":749,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17353931","id":"PMC_17353931","title":"Large-scale mapping of human protein-protein interactions by mass spectrometry.","date":"2007","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/17353931","citation_count":733,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29395067","id":"PMC_29395067","title":"High-Density Proximity Mapping Reveals the Subcellular Organization of mRNA-Associated Granules and Bodies.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29395067","citation_count":580,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28302793","id":"PMC_28302793","title":"Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.","date":"2017","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/28302793","citation_count":533,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8125298","id":"PMC_8125298","title":"Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.","date":"1994","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8125298","citation_count":492,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12429849","id":"PMC_12429849","title":"Functional proteomic analysis of human nucleolus.","date":"2002","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/12429849","citation_count":391,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21963094","id":"PMC_21963094","title":"Global identification of modular cullin-RING ligase substrates.","date":"2011","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21963094","citation_count":354,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22046132","id":"PMC_22046132","title":"The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors.","date":"2011","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/22046132","citation_count":341,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21145461","id":"PMC_21145461","title":"Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics.","date":"2010","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21145461","citation_count":318,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21139048","id":"PMC_21139048","title":"Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level.","date":"2010","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/21139048","citation_count":262,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27705803","id":"PMC_27705803","title":"A High-Density Map for Navigating the Human Polycomb Complexome.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27705803","citation_count":216,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27173435","id":"PMC_27173435","title":"An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27173435","citation_count":211,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29568061","id":"PMC_29568061","title":"An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29568061","citation_count":201,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8661,"output_tokens":3093,"usd":0.036189},"stage2":{"model":"claude-opus-4-6","input_tokens":6459,"output_tokens":2367,"usd":0.137205},"total_usd":0.381108,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":20086,"output_tokens":2944,"usd":0.052209},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6524,"output_tokens":2842,"usd":0.155505}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"LAS1L is a nucleolar protein required for ribosome biogenesis; its depletion inhibits rRNA processing, prevents mature 28S rRNA synthesis, impairs 60S ribosomal subunit synthesis, and causes p53-dependent G1 cell cycle arrest.\",\n      \"method\": \"siRNA knockdown, rRNA processing assays (Northern blot), cell proliferation assays, flow cytometry\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KD with multiple defined cellular phenotypes (rRNA processing defect, G1 arrest, p53 dependency), replicated in follow-up work\",\n      \"pmids\": [\"20647540\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"LAS1L forms a novel nucleolar complex with the mammalian Rix1 complex components PELP1, TEX10, and WDR18, together with NOL9 and SENP3; this complex co-fractionates with the 60S preribosomal subunit and is required for pre-rRNA ITS2 processing. Nucleolar localization of this complex requires active RNA Pol I transcription and the SUMO-specific protease SENP3.\",\n      \"method\": \"Co-immunoprecipitation, sucrose gradient fractionation, siRNA knockdown, rRNA processing assays, RNA Pol I inhibition\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, co-fractionation, functional epistasis with SENP3 and RNA Pol I, multiple orthogonal methods\",\n      \"pmids\": [\"22190735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Las1 (yeast ortholog of LAS1L) is required for pre-rRNA processing at both ends of ITS2: it is needed for Rrp6-dependent 5.8S rRNA 3′ end formation and Rat1-dependent 25S rRNA 5′ end formation, indicating coordination of processing at both ends of ITS2.\",\n      \"method\": \"Genetic depletion in budding yeast and RNAi in human cells, Northern blot rRNA processing analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — parallel yeast and human cell experiments, multiple orthogonal methods, replicated finding\",\n      \"pmids\": [\"22083961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Yeast Las1 (ortholog of LAS1L) interacts with Grc3 polynucleotide kinase as a major binding partner; both proteins co-purify with the Nsa1- and Rix1-containing pre-60S particle. Depletion of either Las1 or Grc3 causes accumulation of 27S and 7S rRNA intermediates and impairs 60S subunit synthesis; the kinase activity of Grc3 is required for efficient pre-rRNA processing.\",\n      \"method\": \"Co-immunoprecipitation, sucrose gradient fractionation, genetic depletion in S. cerevisiae, Northern blot, kinase-dead mutant analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — Co-IP, kinase-dead mutagenesis, fractionation, and processing assays in yeast ortholog\",\n      \"pmids\": [\"23175604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Las1 (yeast ortholog of LAS1L) is the endoribonuclease that cleaves 27SB pre-rRNA at site C2, producing a 5′-OH end on 26S pre-rRNA and a 2′,3′-cyclic phosphate on 7S pre-rRNA. It assembles with Grc3, Rat1, and Rai1 into a four-subunit RNA processome (Las1 complex). After Las1 cleavage, Grc3 phosphorylates the 5′-OH of 26S pre-rRNA, enabling Rat1-Rai1 exonuclease to generate 25S pre-rRNA, completing coordinated ITS2 removal.\",\n      \"method\": \"In vitro RNA cleavage assays, biochemical reconstitution of the four-subunit complex, mutational analysis, yeast genetics\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution of endonuclease activity, sequential enzymatic mechanism defined with mutagenesis; foundational discovery paper\",\n      \"pmids\": [\"26638174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Las1 (yeast ortholog of LAS1L) is a HEPN-domain endoribonuclease whose C2-site RNA cleavage specificity is programmed by its binding partner Grc3; Grc3 drives Las1 to the C2 site both in vitro and in vivo. Reciprocally, Las1 activates Grc3 kinase activity specifically toward single-stranded RNA. Together they assemble as a tetramer required for competent rRNA processing, functionally analogous to RNaseL/Ire1 RNA splicing enzymes.\",\n      \"method\": \"In vitro RNA cleavage assays, kinase activity assays, mutagenesis of active sites, yeast in vivo experiments, biochemical reconstitution of tetrameric complex\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution, mutagenesis, in vivo validation, mechanistic reciprocal activation defined\",\n      \"pmids\": [\"28652339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Grc3 polynucleotide kinase (Las1 partner) has distinct substrate preference for RNA over DNA; specific conserved residues at the Grc3 kinase active site are required for Grc3-directed Las1-mediated pre-rRNA C2 cleavage both in vitro and in vivo, demonstrating direct molecular crosstalk coupling cleavage and phosphorylation.\",\n      \"method\": \"In vitro kinase assays with RNA/DNA substrates, site-directed mutagenesis of Grc3 active site, yeast in vivo rRNA processing assays\",\n      \"journal\": \"RNA (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzyme characterization with mutagenesis validated in vivo\",\n      \"pmids\": [\"29440475\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Las1 (yeast ortholog of LAS1L) belongs to the HEPN nuclease family; both HEPN nuclease motifs (RφXXXH) are required for nuclease activity and fidelity. The two HEPN domains come together to form a composite active site, and conformational flexibility between the two HEPN domains is important for proper RNA cleavage.\",\n      \"method\": \"Systematic mutagenesis of HEPN motif residues, in vitro RNA cleavage assays, reconstituted Las1 HEPN-HEPN′ chimeras, in vivo yeast complementation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — comprehensive mutagenesis combined with in vitro cleavage assays and in vivo validation\",\n      \"pmids\": [\"32220933\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"hnRNPA1 directly binds to LAS1L pre-mRNA at two specific intronic sequences (UAGGGU and UGGGGU in Intron 9) to inhibit splicing of LAS1L exon 9, thereby regulating the ratio of long (LAS1L-L) to short (LAS1L-S) isoforms; the resulting isoform ratio modulates migration, invasion, and EMT in lung cancer cells.\",\n      \"method\": \"RIP assay, RNA pull-down, AGE splicing assay, Transwell migration/invasion assay, siRNA knockdown\",\n      \"journal\": \"Frontiers in oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — RIP and pull-down establish direct binding, functional consequence shown by isoform manipulation, single lab\",\n      \"pmids\": [\"35814393\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LAS1 interacts with NOL9; covalent binding of the compound HEN-463 to the C264 site of LAS1 disrupts the LAS1–NOL9 interaction and causes LAS1 translocation from nucleolus to cytoplasm, thereby inhibiting 28S rRNA maturation and activating the NPM1-MDM2-p53 pathway.\",\n      \"method\": \"Covalent compound targeting, co-immunoprecipitation, subcellular fractionation/localization, rRNA processing assay, western blot (p53 pathway)\",\n      \"journal\": \"Pharmacological research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct chemical perturbation of LAS1–NOL9 interaction with mechanistic downstream readouts; single lab, limited mutagenesis\",\n      \"pmids\": [\"36796466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"USP36 interacts with Las1L and NOL9, stabilizes them via deubiquitination, and additionally mediates SUMOylation of Las1L at lysine K565. SUMOylation at K565 is essential for ITS2 pre-rRNA processing but not for Las1L protein levels or Las1L–NOL9 complex formation, as the K565R mutant fails to rescue ITS2 processing defects caused by Las1L knockdown.\",\n      \"method\": \"Co-immunoprecipitation, deubiquitination assay, SUMOylation assay, site-directed mutagenesis (K565R), siRNA rescue experiments, Northern blot ITS2 processing assay\",\n      \"journal\": \"Cancer research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — biochemical identification of writer (USP36) for both deubiquitination and SUMOylation, mutagenesis of modification site with functional rescue assay, multiple orthogonal methods\",\n      \"pmids\": [\"39356143\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"LAS1L (and its yeast ortholog Las1) is an essential nucleolar HEPN-domain endoribonuclease that cleaves 27SB pre-rRNA at site C2 within ITS2, working in a tetrameric complex with Grc3 polynucleotide kinase (which programs Las1 cleavage specificity and is reciprocally activated by Las1), and together with Rat1-Rai1 exonuclease to complete coordinated ITS2 removal during 60S ribosomal subunit biogenesis; in mammalian cells, Las1L forms a larger nucleolar complex with the Rix1 components PELP1/TEX10/WDR18, NOL9, and SENP3, whose nucleolar localization requires active RNA Pol I transcription and SENP3, and Las1L activity is further regulated by USP36-mediated deubiquitination and SUMOylation at K565, the latter being specifically required for ITS2 processing.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"LAS1L is a nucleolar protein required for cell proliferation and ribosome biogenesis; depletion of LAS1L inhibits rRNA processing, blocks synthesis of mature 28S rRNA, and causes p53-dependent G1 arrest.\",\n      \"method\": \"siRNA knockdown in human cells, rRNA processing analysis (Northern blot), cell cycle analysis by flow cytometry\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KD with defined cellular and molecular phenotypes, multiple orthogonal readouts\",\n      \"pmids\": [\"20647540\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"LAS1L forms a novel nucleolar complex with PELP1, TEX10, WDR18 (mammalian Rix1 complex homologues), NOL9, and SENP3 that co-fractionates with the 60S preribosomal subunit; depletion of complex members causes p53-dependent G1 arrest and defects in ITS2 pre-rRNA processing; nucleolar localization of this complex requires active RNA Pol I transcription and the SUMO protease SENP3.\",\n      \"method\": \"Co-immunoprecipitation, sucrose gradient fractionation, siRNA knockdown, rRNA processing analysis, RNA Pol I inhibition, SENP3 depletion\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IPs, co-fractionation, multiple knockdowns with defined molecular phenotypes\",\n      \"pmids\": [\"22190735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In both budding yeast and human cells, Las1/LAS1L is required for ITS2 processing: in yeast it is needed for Rrp6-dependent formation of the 5.8S rRNA 3' end and for Rat1-dependent formation of the 25S rRNA 5' end, indicating coordinated pre-rRNA processing at both ends of ITS2.\",\n      \"method\": \"Genetic depletion/mutant analysis in S. cerevisiae and human cells, Northern blot rRNA processing analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cross-species genetic analysis with defined molecular phenotypes replicated in two organisms\",\n      \"pmids\": [\"22083961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Yeast Las1 functions in ribosome biogenesis by associating with 27S rRNA and the Nsa1/Rix1-containing pre-60S particle; Grc3 is a major Las1-interacting protein, and the kinase activity of Grc3 is required for efficient pre-rRNA processing — depletion of either Las1 or Grc3 causes accumulation of 27S and 7S rRNA intermediates and impairs 60S subunit synthesis.\",\n      \"method\": \"Co-immunoprecipitation, sucrose gradient fractionation, yeast genetic depletion, in vivo kinase assay, Northern blot\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, functional kinase requirement established by mutagenesis\",\n      \"pmids\": [\"23175604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Las1 is the long-sought endonuclease that cleaves 27SB pre-rRNA at site C2, generating a 5'-OH end at 26S pre-rRNA and a 2',3'-cyclic phosphate at the 3' end of 7S pre-rRNA; it assembles with Grc3, Rat1, and Rai1 into a four-subunit RNA processome (Las1 complex) where Grc3 subsequently phosphorylates the 5'-OH of 26S pre-rRNA enabling Rat1-Rai1 exonuclease to generate 25S' pre-rRNA, thus coordinately removing ITS2.\",\n      \"method\": \"In vitro reconstitution of endonuclease activity, biochemical fractionation, mutational analysis, RNA substrate assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution of enzymatic activities with mutational validation, multiple orthogonal assays\",\n      \"pmids\": [\"26638174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The Grc3 polynucleotide kinase programs Las1 endoribonuclease for specific C2 cleavage: Grc3 drives Las1 nuclease activity to the targeted C2 site both in vitro and in vivo; Las1 reciprocally activates Grc3 kinase activity exclusively toward single-stranded RNA; together they form a tetrameric complex required for competent rRNA processing, with parallels to the RNaseL/Ire1 RNA splicing family.\",\n      \"method\": \"In vitro endonuclease and kinase assays, yeast genetics, co-immunoprecipitation, biochemical reconstitution of tetrameric complex\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis confirmed in vivo, bidirectional activation demonstrated\",\n      \"pmids\": [\"28652339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Grc3 has distinct substrate preference for RNA (over DNA) as a polynucleotide kinase; specific conserved residues at the Grc3 kinase active site are required for Grc3-directed Las1-mediated pre-rRNA cleavage both in vitro and in vivo; the Grc3–Las1 crosstalk directly couples cleavage and phosphorylation during pre-rRNA processing.\",\n      \"method\": \"In vitro kinase assays with RNA/DNA substrates, site-directed mutagenesis of kinase active site, in vivo yeast complementation assays\",\n      \"journal\": \"RNA (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assays with mutagenesis validated in vivo\",\n      \"pmids\": [\"29440475\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Las1 is a HEPN domain-containing endoribonuclease; both HEPN nuclease motifs (forming a composite active site) are required for Las1 nuclease activity and fidelity; conformational flexibility of the two HEPN domains is important for proper RNA cleavage; systematic mutagenesis defined the consensus Las1 HEPN motif with canonical and specialized elements.\",\n      \"method\": \"In vitro nuclease assays, in vivo S. cerevisiae complementation, systematic site-directed mutagenesis, Las1 HEPN-HEPN' chimera reconstitution, sequence analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with extensive mutagenesis, validated in vivo\",\n      \"pmids\": [\"32220933\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Covalent binding of the compound HEN-463 to C264 of LAS1 disrupts the LAS1–NOL9 interaction, causing LAS1 translocation to the cytoplasm and inhibiting 28S rRNA maturation; this activates the NPM1-MDM2-p53 pathway leading to p53 stabilization in NPM1-mutant AML cells.\",\n      \"method\": \"Chemical biology (covalent inhibitor), co-immunoprecipitation, subcellular fractionation, rRNA processing analysis, cell viability and apoptosis assays\",\n      \"journal\": \"Pharmacological research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct covalent targeting with defined molecular consequences, but single-lab study\",\n      \"pmids\": [\"36796466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"USP36 interacts with both LAS1L and NOL9, stabilizes them via deubiquitination, and mediates SUMOylation of LAS1L predominantly at lysine K565; the K565R SUMOylation-deficient mutant cannot rescue ITS2 processing defects caused by endogenous LAS1L knockdown, demonstrating that USP36-mediated LAS1L SUMOylation is required for ITS2 pre-rRNA processing.\",\n      \"method\": \"Co-immunoprecipitation, deubiquitination assays, SUMOylation assays, site-directed mutagenesis (K565R), siRNA rescue experiments, Northern blot rRNA processing analysis\",\n      \"journal\": \"Cancer research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IPs, enzymatic assays, mutagenesis rescue experiment with defined molecular phenotype\",\n      \"pmids\": [\"39356143\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"hnRNPA1 directly binds to LAS1L pre-mRNA at two intronic sites (UAGGGU and UGGGGU in intron 9) to inhibit splicing of LAS1L exon 9; the ratio of long (LAS1L-L) to short (LAS1L-S) isoforms regulated by hnRNPA1 promotes migration, invasion, and EMT in lung cancer cells.\",\n      \"method\": \"RIP assay, RNA pull-down assay, AGE splicing assay, Transwell migration/invasion assays, siRNA knockdown\",\n      \"journal\": \"Frontiers in oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct RNA binding demonstrated by RIP and pull-down, functional consequence of isoform ratio established, single lab\",\n      \"pmids\": [\"35814393\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"LAS1L is a nucleolar HEPN-domain endoribonuclease that, together with the polynucleotide kinase NOL9/Grc3 (and the Rat1-Rai1 exonuclease), forms the Las1 complex required for coordinated cleavage of 27SB pre-rRNA at site C2 and subsequent phosphorylation and exonucleolytic trimming to remove ITS2, thereby driving 60S ribosomal subunit maturation; in mammalian cells it additionally assembles with the Rix1-like complex (PELP1, TEX10, WDR18) and SENP3 in a nucleolar complex whose localization depends on active RNA Pol I transcription, and its activity is post-translationally regulated by USP36-mediated deubiquitination and SUMOylation at K565.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"LAS1L is an essential nucleolar HEPN-domain endoribonuclease that catalyzes the cleavage of ITS2 in pre-rRNA at site C2, a key step in 60S ribosomal subunit biogenesis and mature 28S rRNA production [PMID:26638174, PMID:20647540]. LAS1L functions within a tetrameric complex with the polynucleotide kinase Grc3/NOL9, which reciprocally programs Las1L cleavage specificity while Las1L activates Grc3 kinase activity toward RNA; following C2 cleavage, Grc3 phosphorylates the resulting 5′-OH end to enable Rat1-mediated exonucleolytic trimming that completes ITS2 removal [PMID:28652339, PMID:26638174]. In mammalian cells, LAS1L assembles with the Rix1 complex components PELP1, TEX10, and WDR18, together with NOL9 and SENP3, into a nucleolar complex whose localization depends on active RNA Pol I transcription and SENP3, and whose activity is regulated by USP36-mediated deubiquitination and SUMOylation at K565 [PMID:22190735, PMID:39356143]. Loss of LAS1L function triggers accumulation of pre-rRNA intermediates, impaired 60S subunit production, and p53-dependent G1 cell cycle arrest [PMID:20647540].\",\n  \"teleology\": [\n    {\n      \"year\": 2010,\n      \"claim\": \"Establishing that LAS1L is required for rRNA maturation and ribosome biogenesis resolved its cellular function as a nucleolar factor essential for 28S rRNA synthesis and 60S subunit production, linking its loss to p53-dependent cell cycle arrest.\",\n      \"evidence\": \"siRNA knockdown in human cells with Northern blot rRNA analysis, flow cytometry, and proliferation assays\",\n      \"pmids\": [\"20647540\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Catalytic mechanism unknown\", \"Direct versus indirect role in rRNA processing unclear\", \"Identity of interacting partners not established\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identification of the LAS1L-PELP1-TEX10-WDR18-NOL9-SENP3 nucleolar complex and its requirement for ITS2 processing defined the macromolecular context in which LAS1L operates and revealed that nucleolar localization depends on RNA Pol I transcription and SENP3.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation, sucrose gradient co-fractionation, siRNA epistasis, and RNA Pol I inhibition in mammalian cells; parallel yeast and human Northern blot rRNA processing\",\n      \"pmids\": [\"22190735\", \"22083961\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether LAS1L is itself the nuclease or an accessory factor remained unknown\", \"Role of SENP3 in regulating LAS1L activity versus localization not dissected\", \"Stoichiometry of the complex not determined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Discovery that Las1 directly partners with Grc3 polynucleotide kinase on pre-60S particles and that Grc3 kinase activity is required for rRNA processing identified the enzymatic partnership central to ITS2 maturation.\",\n      \"evidence\": \"Co-immunoprecipitation, kinase-dead mutagenesis, sucrose gradient fractionation, and Northern blot in S. cerevisiae\",\n      \"pmids\": [\"23175604\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Las1 itself possesses nuclease activity not yet demonstrated\", \"Mechanism of Grc3–Las1 coupling unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Biochemical reconstitution of the four-subunit Las1–Grc3–Rat1–Rai1 complex proved that Las1 is the C2 endonuclease and defined the sequential cleavage-phosphorylation-exonuclease mechanism for ITS2 removal.\",\n      \"evidence\": \"In vitro RNA cleavage assays with reconstituted complex, mutational analysis, and yeast genetics\",\n      \"pmids\": [\"26638174\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of C2 site recognition unknown\", \"Nuclease active site architecture not defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstration that Grc3 programs Las1 cleavage specificity for the C2 site while Las1 reciprocally activates Grc3 kinase activity established a bidirectional allosteric activation mechanism within the Las1–Grc3 tetramer.\",\n      \"evidence\": \"In vitro cleavage and kinase assays, active-site mutagenesis, and yeast in vivo validation\",\n      \"pmids\": [\"28652339\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of reciprocal activation not resolved\", \"Whether mammalian LAS1L–NOL9 operates identically not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Characterization of Grc3 substrate preference for RNA and identification of active-site residues required for coupling kinase activity to Las1 cleavage deepened understanding of the molecular crosstalk between the two enzymatic centers.\",\n      \"evidence\": \"In vitro kinase assays with RNA/DNA substrates, site-directed mutagenesis, yeast rRNA processing assays\",\n      \"pmids\": [\"29440475\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of the Las1–Grc3 interface available\", \"Whether substrate channeling occurs in the complex unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Systematic mutagenesis of both HEPN motifs (RφXXXH) confirmed that Las1 forms a composite HEPN active site from two domains, with conformational flexibility between them required for proper cleavage fidelity.\",\n      \"evidence\": \"HEPN motif mutagenesis, in vitro cleavage assays, HEPN–HEPN′ chimeras, yeast complementation\",\n      \"pmids\": [\"32220933\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"High-resolution structure of the HEPN dimer not determined\", \"Mechanism controlling conformational transitions unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Discovery that USP36 deubiquitinates and stabilizes LAS1L while also mediating its SUMOylation at K565—a modification specifically required for ITS2 processing but not for complex formation—revealed a post-translational regulatory switch governing LAS1L enzymatic function.\",\n      \"evidence\": \"Co-IP, deubiquitination and SUMOylation assays, K565R mutagenesis with siRNA rescue, Northern blot in human cells\",\n      \"pmids\": [\"39356143\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How SUMOylation at K565 activates LAS1L catalytic activity mechanistically unknown\", \"SUMO E3 ligase responsible not identified\", \"Whether USP36 regulation is cell-cycle dependent not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution structure of the mammalian LAS1L–NOL9 complex and the mechanism by which K565 SUMOylation activates endonuclease function remain to be determined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No cryo-EM or crystal structure of full mammalian LAS1L complex\", \"Structural basis of C2 site recognition by mammalian LAS1L not defined\", \"Relationship between SENP3-dependent deSUMOylation and USP36-mediated SUMOylation not resolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [4, 5, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [0, 1, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [4, 5, 7]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 2, 4]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"complexes\": [\n      \"Las1–Grc3(NOL9)–Rat1–Rai1 processome\",\n      \"LAS1L–PELP1–TEX10–WDR18–NOL9–SENP3 (Rix1-associated complex)\"\n    ],\n    \"partners\": [\n      \"NOL9\",\n      \"PELP1\",\n      \"TEX10\",\n      \"WDR18\",\n      \"SENP3\",\n      \"USP36\",\n      \"HNRNPA1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"LAS1L is a nucleolar HEPN-domain endoribonuclease essential for 60S ribosomal subunit maturation, functioning as the endonuclease that cleaves 27SB pre-rRNA at site C2 within ITS2 [PMID:26638174]. It assembles with the polynucleotide kinase NOL9/Grc3 into a tetrameric complex in which the two enzymes reciprocally activate each other: LAS1L cleavage generates a 5'-OH substrate that NOL9/Grc3 phosphorylates to enable Rat1-Rai1 exonucleolytic trimming, thereby coordinately removing ITS2 [PMID:26638174, PMID:28652339]. In mammalian cells, LAS1L further associates with the Rix1-like complex (PELP1, TEX10, WDR18) and the SUMO protease SENP3, whose nucleolar localization depends on active RNA Pol I transcription, and its activity is post-translationally regulated by USP36-mediated deubiquitination and SUMOylation at K565, both required for ITS2 processing [PMID:22190735, PMID:39356143]. Loss of LAS1L blocks 28S rRNA synthesis, triggers nucleolar stress, and activates p53-dependent G1 arrest [PMID:20647540].\",\n  \"teleology\": [\n    {\n      \"year\": 2010,\n      \"claim\": \"Establishing that LAS1L is required for ribosome biogenesis resolved the cellular role of this uncharacterized nucleolar protein, showing that its depletion blocks 28S rRNA maturation and triggers p53-dependent growth arrest.\",\n      \"evidence\": \"siRNA knockdown in human cells with Northern blot rRNA processing analysis and flow cytometry\",\n      \"pmids\": [\"20647540\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Enzymatic activity unknown\", \"Direct rRNA substrate not identified\", \"Mechanism of rRNA processing block undefined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identification of the LAS1L-PELP1-TEX10-WDR18-NOL9-SENP3 nucleolar complex and its co-fractionation with pre-60S subunits established the multiprotein context in which LAS1L functions and linked its localization to active RNA Pol I transcription and SENP3-dependent SUMOylation.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation, sucrose gradient fractionation, siRNA knockdown, and RNA Pol I inhibition in human cells; cross-species genetic analysis in yeast and human cells\",\n      \"pmids\": [\"22190735\", \"22083961\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether LAS1L is the direct endonuclease or an accessory factor was unknown\", \"Stoichiometry of the complex undefined\", \"Role of individual subunits in catalysis unresolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstration that Grc3/NOL9 is the principal Las1-interacting partner and that its kinase activity is required for pre-rRNA processing established the functional coupling between Las1 and Grc3 within the pre-60S particle.\",\n      \"evidence\": \"Co-immunoprecipitation, yeast genetic depletion, in vivo kinase assays, Northern blot\",\n      \"pmids\": [\"23175604\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Las1 catalytic activity not yet demonstrated biochemically\", \"Nature of the Las1-Grc3 crosstalk unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"In vitro reconstitution proved Las1 is the long-sought C2 endonuclease, generating a 2',3'-cyclic phosphate and a 5'-OH that Grc3 phosphorylates to enable Rat1-Rai1 exonuclease activity — resolving how ITS2 removal is coordinately executed by a four-subunit Las1 complex.\",\n      \"evidence\": \"In vitro endonuclease reconstitution with purified components, mutational analysis, RNA substrate assays\",\n      \"pmids\": [\"26638174\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of C2 site specificity unknown\", \"How Grc3 directs Las1 to C2 unresolved\", \"HEPN domain contribution not yet dissected\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Reciprocal activation between Las1 and Grc3 was demonstrated — Grc3 programs Las1 for site-specific C2 cleavage while Las1 activates Grc3 kinase toward RNA — revealing the bidirectional allosteric mechanism governing coordinated ITS2 processing.\",\n      \"evidence\": \"In vitro endonuclease/kinase assays, yeast genetics, biochemical reconstitution of tetrameric complex\",\n      \"pmids\": [\"28652339\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of allosteric communication unknown\", \"Whether conformational states regulate activity in vivo untested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Characterization of Grc3 substrate specificity (RNA over DNA) and identification of active-site residues required for Las1-coupled cleavage refined the kinase mechanism and confirmed that cleavage–phosphorylation coupling is direct.\",\n      \"evidence\": \"In vitro kinase assays with RNA/DNA substrates, site-directed mutagenesis, yeast complementation\",\n      \"pmids\": [\"29440475\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinetic parameters of coupled reaction not determined\", \"Whether additional cofactors modulate kinase selectivity unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Systematic mutagenesis of the Las1 HEPN domain defined the composite active site formed by two HEPN motifs, established that conformational flexibility between HEPN domains is required for cleavage fidelity, and confirmed Las1 as a bona fide HEPN endoribonuclease.\",\n      \"evidence\": \"In vitro nuclease assays, HEPN-HEPN' chimera reconstitution, extensive site-directed mutagenesis, yeast complementation\",\n      \"pmids\": [\"32220933\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of Las1 HEPN domain available\", \"Mechanism of cleavage site selection at nucleotide resolution unresolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Discovery that hnRNPA1 regulates LAS1L alternative splicing by binding intronic sequences to modulate the ratio of long and short isoforms revealed a layer of pre-mRNA-level regulation with phenotypic consequences for cell migration.\",\n      \"evidence\": \"RIP assay, RNA pull-down, splicing assays, Transwell migration/invasion in lung cancer cells\",\n      \"pmids\": [\"35814393\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional difference between LAS1L-L and LAS1L-S isoforms in ribosome biogenesis not defined\", \"Relevance beyond lung cancer cells untested\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Covalent targeting of LAS1L at C264 by HEN-463 disrupted the LAS1L–NOL9 interaction, caused cytoplasmic translocation, and blocked 28S rRNA maturation, activating the NPM1-MDM2-p53 axis — demonstrating LAS1L druggability and linking ribosome biogenesis disruption to p53 activation in AML cells.\",\n      \"evidence\": \"Chemical biology (covalent inhibitor), co-immunoprecipitation, subcellular fractionation, rRNA processing analysis in NPM1-mutant AML cells\",\n      \"pmids\": [\"36796466\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Selectivity of HEN-463 across the proteome not fully profiled\", \"In vivo efficacy untested\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"USP36 was shown to deubiquitinate and stabilize LAS1L and NOL9, and to mediate SUMOylation of LAS1L at K565; the K565R mutation failed to rescue ITS2 processing, establishing that SUMOylation is functionally required for LAS1L endonuclease activity in cells.\",\n      \"evidence\": \"Co-immunoprecipitation, deubiquitination/SUMOylation assays, K565R mutagenesis rescue, Northern blot rRNA processing\",\n      \"pmids\": [\"39356143\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How SUMOylation at K565 modulates LAS1L activity mechanistically is unknown\", \"Whether additional SUMOylation sites contribute is untested\", \"Structural impact of SUMO conjugation unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"No high-resolution structure of the human LAS1L–NOL9 complex exists, the mechanism by which HEPN domain conformational dynamics achieve C2 site selectivity is unresolved, and the functional distinction between LAS1L splice isoforms in ribosome biogenesis remains undefined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No cryo-EM or crystal structure of human Las1 complex\", \"Nucleotide-level basis of C2 recognition unknown\", \"In vivo roles of LAS1L-L versus LAS1L-S isoforms undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [4, 5, 7]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [4, 5, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [4, 5, 7]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 2, 4, 5, 7, 9]}\n    ],\n    \"complexes\": [\n      \"Las1 complex (Las1-Grc3-Rat1-Rai1)\",\n      \"Rix1-like complex (PELP1-TEX10-WDR18-LAS1L-NOL9-SENP3)\"\n    ],\n    \"partners\": [\n      \"NOL9\",\n      \"PELP1\",\n      \"TEX10\",\n      \"WDR18\",\n      \"SENP3\",\n      \"USP36\",\n      \"hnRNPA1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}